# Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes

> **NCT01364584** · NA · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 23 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01364584
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364584, "Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01364584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*